The invention relates to a pharmaceutical composition comprising an inhibitor of SLY-1 (SH3 domain protein expressed in lymphocytes).Further Information: PDF Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V….
The invention consists of a new system for the expression of proteins in E. coli and its applications.
Compared to the state of the art the new autodisplay…
This invention covers a new process that allows the stabilization and activation of sensitive catalysts (respectively enzymes) to be used in organic…
The invention concerns a market ready and provable technical process for the “super activation” of polysaccharides (e.g. cellulose, starch, chitin) for the…
The invention affects the novel bacterial enzyme 1,5-anhydro-D-fructose-reductase. In a regio- and stereoselective reaction 1,5-anhydro-D-fructose (AF) is…
Since the discovery that short double-strand RNA molecules (siRNAs) can trigger sequence-specific degradation of target RNA in cells, great efforts are going…